Skip to main content

Advertisement

SpringerLink
Log in

Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Background

Transurethral removal of prostatic tissue is the treatment choice for benign prostatic enlargement and benign prostatic obstruction. Urodynamic results are directly linked to the amount of removed tissue which, however, is directly associated with intra- and postoperative morbidity. Transurethral laser operations of the prostate offer the advantage of decreased bleeding complications and the possibility to treat patients with bleeding disorders or anticoagulative treatment. The aim of the article is to present a novel technique of complete transurethral removal of the transition zone (enucleation) with the support of the Thulium laser to combine complete anatomical enucleation and maximum urodynamic efficacy with minimal side-effects.

Materials and methods

We present five distinct surgical steps for transurethral complete removal of the transition zone of the prostate (Thulium laser enucleation of the prostate, ThuLEP). Surgical steps are presented in chronological order with the help of intraoperative pictures. Laser energy of 70–90 W is only used for the incision at the verumontanum and bladder neck for removal of the middle lobe, whereas laser energy of 30 W was only used for coagulation of small vessel crossing the surgical capsule towards the transition zone and bladder neck for dissection of the lateral lobes. The lobes themselves are liberated by blunt dissection.

Conclusions

ThuLEP offers complete removal of the transition zone no matter what prostatic size. The techniques combine maximum efficacy with minimal side-effects. Clinical results comparing ThuLEP with open prostatectomy or transurethral resection are awaited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Herrmann TR, Georgiou A, Bach T, Gross AJ, Oelke M (2009) Laser treatments of the prostate vs TURP/open prostatectomy: systematic review of urodynamic data. Minerva Urol Nefrol 61(3):309–324

    CAS  PubMed  Google Scholar 

  2. Tan AH, Gilling PJ, Kennett KM et al (2003) A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 170:1270

    Article  CAS  PubMed  Google Scholar 

  3. Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19(1):25–31

    Article  PubMed  Google Scholar 

  4. Bach T, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs 120 W thulium:yttrium-aluminiumgarnet 2 m continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU [Epub ahead of print]. doi: 10.1111/j.1464-410X.2009.09059.x

  5. Bach T, Herrmann TR, Cellarius C, Gross AJ (2007) Bladder neck incision using a 70 W 2 micron continuous wave laser (RevoLix). World J Urol 25(3):263–267

    Article  PubMed  Google Scholar 

  6. Bach T, Herrmann TR, Ganzer R, Gross AJ (2007) RevoLix™ vaporesection of the prostate: initial results after 54 patients with an one-year follow-up. World J Urol 25(3):257–262

    Article  PubMed  Google Scholar 

  7. Bach T, Herrmann TR, Ganzer R, Blana A, Burchardt M, Gross AJ, Urologe A (2009) Thulium:YAG vaporesection of the prostate: first results. Urologe A 48(5):529–534

    Article  CAS  PubMed  Google Scholar 

  8. Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium: YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545

    Article  CAS  PubMed  Google Scholar 

  9. Bach T, Herrmann TR, Haecker A, Michel MS, Gross A (2009) Thulium:yttrium-aluminium-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104(3):361–364

    Article  PubMed  Google Scholar 

  10. Bach T, Netsch Ch, Haecker A, Michel MS, Herrmann TRW, Gross AJ (2009) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol [Epub ahead of print]

  11. Imkamp F, Bach T, Gross AJ, Kuczyk MA, Herrmann TR (2009) ThuLEP—Thulium laser enucleation of the prostate. J Endourol 23(Suppl 1):24

    Google Scholar 

  12. McConnel JD, Barry MJ, Bruskewitz RC et al (1994) Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline, Number 8. Chapters 10-14. US: Department of Health and Human Services, Public Health Service, Agency for Health Care policy and research

  13. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG (2008) Urology Section of the Bavarian Working Group for Quality Assurance. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246–249

    Article  PubMed  Google Scholar 

  14. Holtgrewe HL, Valk WL (1962) Factors influencing the mortality, morbidity of transurethral prostatectomy: a study of 2, 015 cases. J Urol 87:450

    CAS  PubMed  Google Scholar 

  15. Melchior J, Valk WL, Foret JD, Mebust WK (1974) Transurethral prostatectomy: computerized analysis of 2,223 consecutive cases. J Urol 112:634

    CAS  PubMed  Google Scholar 

  16. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC (1989) Transurethral prostatectomy: immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3, 885 patients. J Urol 141:243–247

    CAS  PubMed  Google Scholar 

  17. Hiraoka Y, Akimoto M (1989) Transurethral enucleation of benign prostatic hyperplasia. J Urol 142(5):1247–1250

    CAS  PubMed  Google Scholar 

  18. Fraundorfer MR, Gilling PJ (1998) Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33(1):69–72

    Article  CAS  PubMed  Google Scholar 

  19. Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225

    Article  PubMed  Google Scholar 

  20. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, Häcker A (2008) Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol 22(5):1041–1045

    Article  PubMed  Google Scholar 

  21. Wendt-Nordahl G, von Löwenstern K, Honeck P et al (2008) Ex-vivo comparison of bipolar plasma-kinetic vaporization of the prostate to low power and high power Greenlight laser. J Endourol 22(Suppl 1): A19, BR4–14

    Google Scholar 

  22. Bach T, Wezel F, Haecker A, Gross AJ, Michel MS (2009) 70 vs 120 W thulium:yttrium-aluminiumgarnet 2 m continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU [Epub ahead of print]. doi:10.1111/j.1464-410X.2009.09059.x

  23. El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9):863–869

    Article  CAS  PubMed  Google Scholar 

  24. Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19(5):550–554

    Article  PubMed  Google Scholar 

  25. Ozden C, Inal G, Adsan O, Yazici S, Ozturk B, Cetinkaya M (2003) Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA. Urol Int 71:150

    Article  PubMed  Google Scholar 

  26. Aus G, Bergdahl S, Frösing R, Lodding P, Pileblad E, Hugosson J (1996) Reference range of prostatespecific antigen after transurethral resection of the prostate. Urology 47:529

    Article  CAS  PubMed  Google Scholar 

  27. Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM (2009) Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology 74(5):1105–1110

    Article  PubMed  Google Scholar 

  28. van Iersel MP, Thomas CM, Witjes WP, de Graaf R, de la Rosette JJ, Debruyne FM (1996) Clinical implications of the rise and fall of prostate specific antigen after laser prostatectomy. Br J Urol 78:742

    PubMed  Google Scholar 

  29. Hai MA, Malek RS (2003) Photoselective vaporization of the prostate: Initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 17:93

    Article  PubMed  Google Scholar 

  30. Te AE, Malloy TR, Stein BS et al (2004) Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 172:1404

    Article  PubMed  Google Scholar 

  31. Hamann MF, Naumann CM, Seif C, van der Horst C, Jünemann KP, Braun PM (2008) Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up. Eur Urol 54(4):902–907

    Article  PubMed  Google Scholar 

  32. Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2009) Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow- up. BJU Int 103(3):352–356

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

There is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology and Urological Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

    Thomas R. W. Herrmann, F. Imkamp & M. Oelke

  2. Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany

    T. Bach & A. J. Gross

  3. Department of Urology, University Clinic, Greifswald, Germany

    A. Georgiou & M. Burchardt

  4. Department of Urology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    M. Oelke

Authors
  1. Thomas R. W. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Bach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Imkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Georgiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Burchardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Oelke
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. J. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas R. W. Herrmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrmann, T.R.W., Bach, T., Imkamp, F. et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28, 45–51 (2010). https://doi.org/10.1007/s00345-009-0503-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-009-0503-0

Keywords

Search

Navigation